medicine

Stanford researcher criticizes FDA plans to reduce oversight of off-label drug use: Pharmaceutial Free For All (No Rules)

Repost From April 2008 Contact: Rosanne Spector manishma@stanford.edu 650-725-5374 Stanford University Medical Center STANFORD, Calif. - Proposed guidelines from the U.S. Food and Drug Administration would allow companies to market…

Read More